Impact of the Application of Injury Prevention Science on Child Safety Over the Last 25 Years
Methods: We reviewed data from WISQARS from 1990 to 2013. We compared years and developed injury rate trend lines. We constructed an overall picture of the total percent change in injury rates in children under the age of 19 years by cause.
Results/Outcomes: Overall, there was a 50% decrease in injury death rates. There was a 55% decline in unintentional injury death rates. By comparison, the decrease for homicide was 54%, and 20% for suicide deaths. Rates of injury declined 84% for motor vehicle occupants, 79% for cyclists, and 68% for pedestrians. In addition, fatal injury rates declined 51% for drowning, 48% for falls, 72% for fires/burns, 75% for residential fires, and 58% for firearms. However, poisoning increased by 30% and suffocation fatalities increased by 54%.
Conclusions: In over 2 decades, there has been a measurable decline in childhood injury rates with a few notable exceptions. Further declines in fatal injury are possible with greater awareness and adoption of proven effective injury prevention interventions.
Implementation of health education strategies, interventions and programs
Public health or related research
Explain the impact of the application of injury prevention science to child and adolescent injury rates over the past 25 years.
Keyword(s): Epidemiology, Child Health
Qualified on the content I am responsible for because: I have been the principal or co-principal investigator on multiple injury prevention research studies. I am the Associate Director of the Injury Prevention Center at Connecticut Children's Medical Center. I am a past presenter at the APHA. Among my scientific interests has been the development of strategies for engaging pediatricians in anticipatory guidance around the primary prevention of childhood injury.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.